Asacol Antitrust Trial Delayed To Let Allergan Appeal Class

Law360, Boston (January 25, 2018, 5:29 PM EST) -- The First Circuit on Thursday granted an indefinite delay of an antitrust trial slated to start next week, allowing Allergan PLC to appeal the certification of a class of unions and grocers who claim the company and a subsidiary manipulated the market with a monopolistic hard switch of available anti-inflammatory drugs.

Three appellate judges issued a three-sentence order postponing any action in the pending trial until they instruct otherwise, overturning a lower judge’s decision to give end purchasers their day in district court as scheduled on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.